Very importantly, Cox’s type1 analysis revealed that ARPP19 expression (p = 0.005) gave additional information in AML patients relapse prognosis after the risk group, and EVI1 mRNA expression, were depicted as significant factors in explaining the probability of relapse. This evidence concerns the gene ARPP19 and acute myeloid leukemia.